Cannabics Pharmaceuticals, Inc. (CNBX) Attains GMP Compliance, Prepares for First Clinical Study of Cannabics SR
Marketwire - Fri Sep 26, 7:30AM CDT
Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX), a developer of advanced medical cannabis therapies, announces that it has achieved Good Manufacturing Practices (GMP) capabilities as the Company moves toward the launch of its first clinical study of Cannabics SR capsules.
Cannabics Pharmaceuticals recruits two former senior Teva Executives to its Advisory Board
Business Wire - Tue Aug 19, 2:23PM CDT
Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) announced today that the Company has made two key appointments to the Company's Advisory Board with the recent recruitment of Mr. Ika Abravanel as senior advisor in the field of operational and strategic planning, and Dr. Sigalit Ariely-Portnoy, as senior advisor in the field of regulation, validation and quality.